Causes, consequences, and treatment of osteoporosis in men.
about
'Adipaging': ageing and obesity share biological hallmarks related to a dysfunctional adipose tissue.Investigation of Vitamin D-Binding Protein Polymorphism Impact on Coronary Artery Disease and Relationship with Longevity: Own Data and a ReviewCommon polymorphism in the LRP5 gene may increase the risk of bone fracture and osteoporosis.Risk of low bone mineral density in patients with rheumatoid arthritis treated with biologicsTargeting metabolic disorders by natural products.The Effect of Polymorphisms in SPP1 on Risk of Fracture: A Case-Control Study.Osteoporosis, vitamin C intake, and physical activity in Korean adults aged 50 years and over.The Effects of Annatto Tocotrienol on Bone Biomechanical Strength and Bone Calcium Content in an Animal Model of Osteoporosis Due to Testosterone Deficiency.New horizons in treatment of osteoporosis.Celiac disease is associated with reduced bone mineral density and increased FRAX scores in the US National Health and Nutrition Examination Survey.Patterns of Pharmacological Treatment for Osteoporosis Among Patients Qualified for Pharmacotherapy According to the National Osteoporosis Foundation Guidelines.A single nucleotide polymorphism in the TGF-β1 gene (rs1982073 C>T) may contribute to increased risks of bone fracture, osteoporosis, and osteoarthritis: a meta-analysis.Fracture-Targeted Delivery of β-Catenin Agonists via Peptide-Functionalized Nanoparticles Augments Fracture Healing.Development of Controlled Drug Delivery Systems for Bone Fracture-Targeted Therapeutic Delivery: A Review.Association of serum testosterone and dehydroepiandrosterone sulfate with rheumatoid arthritis: a case control study.Effect of tocotrienol from Bixa orellana (annatto) on bone microstructure, calcium content, and biomechanical strength in a model of male osteoporosis induced by buserelin.
P2860
Q30385053-6A479836-BBA9-477D-908A-59C56D016207Q31090216-61B1BBE4-9090-4656-B1D4-44FC155AD9A3Q34785840-170B13B7-3213-4769-8686-17F071A6C130Q35792875-0CD56660-D547-482D-A2FE-C79C4EE4C9EFQ35830892-DC73C79B-86F6-48BE-B76A-E02F6912932EQ36377357-7510C1B7-3343-49EE-AA75-D309B66C8EEAQ36829304-A765D308-03FD-4642-96B8-D7337DF3CF0FQ37535500-BD0CEACA-72E3-4A12-AABB-332D2126E891Q37630995-CFFCFE6B-3A26-47F8-BF80-2CB4497F38D8Q39314137-08298E6D-5ADC-4C26-A2F9-3F37DC41CE6AQ40871023-1479B6D3-CC48-42C1-AC60-DE4ED7C67A07Q41697422-E8253635-8100-4D25-A8EA-8F89D1C08324Q47142933-51EF4473-B4DB-41DB-AB61-1CD80D70939AQ51748839-16451B8A-9178-4820-A667-3D4F85625E9FQ55008522-400FF310-1648-4C66-A2B0-A5C1063EAC7CQ55373105-782E8FB3-75D8-402A-962B-3B26425B765F
P2860
Causes, consequences, and treatment of osteoporosis in men.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 22 August 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Causes, consequences, and treatment of osteoporosis in men.
@en
Causes, consequences, and treatment of osteoporosis in men.
@nl
type
label
Causes, consequences, and treatment of osteoporosis in men.
@en
Causes, consequences, and treatment of osteoporosis in men.
@nl
prefLabel
Causes, consequences, and treatment of osteoporosis in men.
@en
Causes, consequences, and treatment of osteoporosis in men.
@nl
P2860
P356
P1476
Causes, consequences, and treatment of osteoporosis in men.
@en
P2093
Jameela Banu
P2860
P304
P356
10.2147/DDDT.S46101
P407
P577
2013-08-22T00:00:00Z